Project Grant R21DA057058
- This $246,012 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will assess whether a digital, survivor-crowdsourced intervention can increase HIV/STI/HCV testing and overdose prevention kit utilization among survivors of sex trafficking living in New York City. The project aims to: 1) develop crowdsourced digital messages to promote HIV/STI/HCV testing and overdose prevention service utilization, 2) compare the...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), totaling $444,826, is focused on adapting and testing an innovative, trauma-informed intervention to reduce overdose risk among women re-entering the community from prison. The key activities include: 1) Adapting the Trust-Based Relational Intervention (TBRI) approach by engaging stakeholders to align it with the unique needs of justice-involved women,...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is focused on evaluating the impact of state policies that facilitate the initiation of medication-based treatment for opioid use disorder (OUD) in emergency department settings. The $794,574 grant will fund a 5-year project to: 1) create a public database of state laws related to emergency department-based initiation of medications for OUD treatment; 2) analyze national...
- This Project Grant award of $783,300 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a research study titled "Informing Best Practices for Substance-Use Treatment with Real-World Evidence for People with Opioid Use Disorder and HIV (STRONG)". The study will be conducted by The Johns Hopkins University in Maryland and aims to comprehensively characterize opioid use disorder (OUD) treatment, co-occurring substance use and...
- This federal Project Grant award of $516,981 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to adapt and evaluate the feasibility, acceptability, and preliminary efficacy of the Safe and Health Experiences (SHE) program for use in opioid use disorder (OUD) care settings (SHE-OUD). The SHE-OUD program aims to screen women seeking OUD treatment for lifetime sexual victimization (SV) and co-occurring issues like...
- This $1,445,488 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to continue the work of the Kentucky Women's Justice Community Overdose Innovation Network - Phase II (WJCOIN-II). The project's overall goal is to reduce overdose risk among women during their re-entry from jail to rural communities in Kentucky. Specific objectives include: Comparing the effectiveness of pre-release Recovery Coaching (RC)...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $431,750 to Rutgers, The State University of New Jersey to conduct research on informing national overdose prevention and treatment strategies for high-risk adolescents. The key objectives of this 2-year project are to: 1) estimate the prevalence of adolescent nonfatal drug overdose and identify high-risk demographic and clinical subgroups,...
- This $147,486 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a mixed-methods study examining the predictors and outcomes of methadone and buprenorphine receipt during incarceration. The study will analyze a longitudinal database on health service use and outcomes among 4,558 incarcerated individuals who received these medications from 2016-2023 at a unified jail and prison system in the Northeast....
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Congressional Directives program (CFDA 93.493) to the AIDS Service Center of Lower Manhattan, Inc., doing business as Alliance for Positive Change. The funding will support the "Women Accessing Options for Opioid Management (OPTIONS)" program, which provides comprehensive substance use disorder (SUD) treatment, harm reduction strategies, and recovery support services...
THE NON-FATAL OVERDOSE CRISIS: SEX AND GENDER DIFFERENCES IN HEALTHCARE UTILIZATION AND HEALTH OUTCOMES OF PEOPLE LIVING WITH AND WITHOUT HIV BETWEEN 2012 AND 2020 - PROJECT SUMMARY/ABSTRACT THE OVERDOSE (OD) CRISIS CONTINUES TO DEVASTATE COMMUNITIES ACROSS NORTH AMERICA. DESPITE 90% OF PARAMEDIC- ATTENDED ODS IN BRITISH COLUMBIA (BC), CANADA BEING NON-FATAL, MUCH OF THE RESEARCH HAS FOCUSED ON FATAL ODS. WHILE MEN ACCOUNT FOR OVER 70% OF FATAL ODS, THERE IS EVIDENCE OF A MORE BALANCED DISTRIBUTION OF MEN AND WOMEN EXPERIENCING NON-FATAL ODS (NFODS); FURTHER, WOMEN HAVE HIGHER MORTALITY RATES IN THE YEAR FOLLOWING AN NFOD. PEOPLE LIVING WITH HIV (PLHIV) ARE DISPROPORTIONATELY AFFECTED BY THE OD CRISIS AND ARE AT INCREASED RISK OF FATAL ODS, YET LITTLE IS KNOWN ABOUT THE LONGER-TERM IMPACTS OF NFODS ON PLHIV IN TERMS OF ADVERSE HEALTH OUTCOMES AND HEALTHCARE UTILIZATION (HCU). CONSIDERING THE INCREASINGLY HIGH RATES OF NFODS, GENDERED DIFFERENCES IN MORTALITY FOLLOWING AN NFOD, AND KNOWLEDGE GAPS CONCERNING HEALTH OUTCOMES FOLLOWING AN NFOD, THIS PROPOSAL SEEKS FUNDING TO INVESTIGATE THE ROLE OF SEX, GENDER, AND HIV STATUS IN DIFFERENTIAL NFOD OUTCOMES. BC'S UNIVERSAL HEALTHCARE SYSTEM AND DATA CENTRALIZATION ENABLED THE COMPARATIVE OUTCOMES AND SERVICE UTILIZATION TRENDS (COAST) STUDY, A POPULATION-BASED LONGITUDINAL COHORT COMPRISED OF LINKED ADMINISTRATIVE HEALTH DATASETS ON ALL KNOWN ADULT PLHIV AND A 10% RANDOM SAMPLE OF THE GENERAL POPULATION IN BC. USING COAST, WE AIM TO: (1) GENERATE ESTIMATES FOR THE INCIDENCE RATES OF FATAL AND NONFATAL ODS AMONG PEOPLE LIVING WITH AND WITHOUT HIV (2012-2020) IN BC; (2) ASSESS AND COMPARE CHANGES IN HEALTH CARE UTILIZATION, CHRONIC COMORBIDITY, AND MORTALITY AMONG PEOPLE LIVING WITH AND WITHOUT HIV WHO EXPERIENCED AN NFOD, MODIFIED BY SEX AND GENDER; AND (3) ASSESS AND COMPARE CHANGES IN HIV TREATMENT OUTCOMES IN PEOPLE LIVING WITH HIV WHO EXPERIENCED AN NFOD, MODIFIED BY SEX AND GENDER. THIS PROJECT WILL ALSO INVOLVE THE DEVELOPMENT OF A COMMUNITY ADVISORY BOARD (CAB) FOR PROPOSED AND FUTURE PROJECTS. THE CAB WILL PROVIDE GUIDANCE TO ENSURE RESEARCH SOUNDNESS AND RELEVANCE TO THE COMMUNITY THROUGHOUT THE RESEARCH AND KNOWLEDGE MOBILIZATION PROCESSES. OUR COLLABORATIVE RESEARCH WILL BE AN OPPORTUNITY TO EXPLORE OTHER RESEARCH POSSIBILITIES INITIATED BY THE CAB AS IMPORTANT FOR WOMEN AND GENDER MINORITIES LIVING WITH AND WITHOUT HIV WHO ARE AFFECTED BY THE OD CRISIS. IN RESPONSE TO THE NATIONAL INSTITUTE ON DRUG ABUSE NOTICE OF SPECIAL INTEREST NOT-DA- 21-021 TO ADVANCE RESEARCH SPECIFIC TO WOMEN AND OTHER UNDERREPRESENTED POPULATIONS INCLUDING GENDER MINORITIES, THIS PROPOSAL WILL INFORM FUTURE CAB-LED CYCLES OF INQUIRY AND ANALYSIS AMONGST OUR TEAM TO ANSWER RELEVANT RESEARCH QUESTIONS AND ADDRESS THE IDENTIFIED NEEDS OF CISGENDER WOMEN AND GENDER MINORITIES LIVING WITH AND WITHOUT HIV AFFECTED BY THE OD CRISIS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $154.7k | 6/12/24 | ||
| Not listed | $136.8k | 6/30/23 | ||
| Not listed | $136.8k | 6/30/23 |